Skip to main content
All lobbying filings

VENABLE LLP

VENABLE LLP filed a Q4 termination report for AMERICAN UROLOGICAL ASSOCIATION on January 9, 2026, reporting $30,000 in lobbying income.

Lobbying for AMERICAN UROLOGICAL ASSOCIATION · Premier urologic association, providing invaluable support to the urologic community

All filings by VENABLE LLP · Everything AMERICAN UROLOGICAL ASSOCIATION has reported

 Filing · LD-2 quarterly report Q4 termination
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 9, 2026
Income
$30,000
What the client paid this registrant for the period.
Client based in
Maryland
Representation ended
Dec 31, 2025
The registrant reported terminating its work for this client.

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Budget/Appropriations

FY 2026 Defense Appropriations funding for Bladder Cancer and Kidney Cancer; FY 2026 Labor Health & Human Services and Education Funding for National Institute of Health; Drug shortages

Health Issues

Specialty Physicians Advancing Rural Care Act (H.R. 4681 / S. 1380); PSA screening for HIM Act (H.R. 1300 / S. 297); Medicare physician payment issues; Telehealth policy issues; Price authorization issues; Medicine Patient Access & Practice Stabilization Act (H.R. 879); Public questions for the record on Senate U.S. Department of Health and Human Services confirmation hearings.

 Bills named in this filing 5

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem